{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T19:46:46Z","timestamp":1775850406205,"version":"3.50.1"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.taap.2023.116448","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T03:10:00Z","timestamp":1678677000000},"page":"116448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Potential cardioprotective and anticancer effects of carvedilol either free or as loaded nanoparticles with or without doxorubicin in solid Ehrlich carcinoma-bearing mice"],"prefix":"10.1016","volume":"465","author":[{"given":"Amr","family":"Zidan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira A.","family":"EL Saadany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal M.","family":"El Maghraby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany A.","family":"Abdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabeha E.","family":"Hedya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9023","key":"10.1016\/j.taap.2023.116448_bb0005","first-page":"1","article-title":"Doxorubicin paradoxically ameliorates tumor-induced inflammation in young mice","volume":"22","author":"Abdelgawad","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2023.116448_bb0010","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.pharep.2014.07.010","article-title":"Effect of propranolol on IL-10, visfatin, Hsp70, iNOS, TLR2, and survivin in amelioration of tumor progression and survival in solid Ehrlich carcinoma-bearing mice","volume":"66","author":"Abdin","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.taap.2023.116448_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jiac.2015.10.001","article-title":"Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice","volume":"22","author":"Adwas","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.taap.2023.116448_bb0020","doi-asserted-by":"crossref","first-page":"32621","DOI":"10.1039\/C8RA06362A","article-title":"Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy","volume":"8","author":"Agarwal","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.taap.2023.116448_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.01399","article-title":"Contribution of angiogenesis to inflammation and Cancer","volume":"9","author":"Aguilar-Cazares","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.taap.2023.116448_bb0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/ejnm-2013-0012","article-title":"Ocular pharmacoscintigraphic and aqueous humoral drug availability of ganciclovir-loaded mucoadhesive nanoparticles in rabbits","volume":"5","author":"Akhter","year":"2013","journal-title":"European J. Nanomed."},{"key":"10.1016\/j.taap.2023.116448_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prp2.381","article-title":"Protective effect of carvedilol alone and coadministered with diltiazem and prednisolone on doxorubicin and 5-fluorouracil-induced hepatotoxicity and nephrotoxicity in rats","volume":"6","author":"Akindele","year":"2018","journal-title":"Pharmacol. Res. Perspect."},{"issue":"e22492","key":"10.1016\/j.taap.2023.116448_bb0040","first-page":"1","article-title":"Antioxidant, antiapoptotic, and antifibrotic effects of the combination of liposomal resveratrol and carvedilol against doxorubicin-induced cardiomyopathy in rats","volume":"34","author":"Alanazi","year":"2020","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.taap.2023.116448_bb0045","first-page":"1","article-title":"Evaluation of the cardiac protection conferred by proanthocyanidins in grape seeds against development of ehrlich solid tumors in mice","volume":"3530296","author":"Aldubayan","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.taap.2023.116448_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/5162687","article-title":"Antineoplastic activity and curative role of avenanthramides against the growth of ehrlich solid tumors in mice","volume":"5162687","author":"Aldubayan","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"e12585","key":"10.1016\/j.taap.2023.116448_bb0055","first-page":"1","article-title":"Ameliorative effects of melatonin against solid Ehrlich carcinoma progression in female mice","volume":"67","author":"Amin","year":"2019","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.taap.2023.116448_bb0060","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cyto.2016.09.004","article-title":"Carvedilol attenuates paraquat-induced lung injury by inhibition of proinflammatory cytokines, chemokine MCP-1, NF-\u03baB activation and oxidative stress mediators","volume":"88","author":"Amirshahrokhi","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.taap.2023.116448_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-5273(02)00233-4","article-title":"The syndrome of cardiac cachexia","volume":"85","author":"Anker","year":"2002","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.taap.2023.116448_bb0070","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bbi.2008.09.005","article-title":"Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer","volume":"23","author":"Antoni","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.taap.2023.116448_bb0075","first-page":"4797","article-title":"Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge","volume":"10","author":"Arzani","year":"2015","journal-title":"Int. J. Nanomedicine"},{"issue":"3203","key":"10.1016\/j.taap.2023.116448_bb0080","first-page":"1","article-title":"Cytoprotective potential of aged garlic extract (AGE) and its active constituent, S-allyl-l-cysteine, in presence of carvedilol during isoproterenol-induced myocardial disturbance and metabolic derangements in rats","volume":"26","author":"Asdaq","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2023.116448_bb0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.biopha.2018.05.002","article-title":"Anti-tumor effects of propranolol: adjuvant activity on a transplanted murine breast cancer model","volume":"104","author":"Ashrafi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2023.116448_bb0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.phrs.2004.04.002","article-title":"The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin?","volume":"50","author":"Awara","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2023.116448_bb0095","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s13277-015-3954-5","article-title":"Synergistic efficacy of \u03b3-radiation together with gallium trichloride and\/or doxorubicin against Ehrlich carcinoma in female mice","volume":"37","author":"Aziz","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.taap.2023.116448_bb0100","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/cncr.11196","article-title":"Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center","volume":"97","author":"Azzola","year":"2003","journal-title":"Cancer: Interdiscip. Int. J. American Cancer Soc."},{"key":"10.1016\/j.taap.2023.116448_bb0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1758834012439738","article-title":"Beta-adrenergic blocking drugs in breast cancer: a perspective review","volume":"4","author":"Barron","year":"2012","journal-title":"Therapeut. Adv. Med. Oncol."},{"key":"10.1016\/j.taap.2023.116448_bb0110","first-page":"882","article-title":"Improved method for the determination of blood glutathione","volume":"61","author":"Beutler","year":"1963","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.taap.2023.116448_bb0115","article-title":"Niosomes: a review on niosomal research in the last decade","volume":"56","author":"Bhardwaj","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"95","key":"10.1016\/j.taap.2023.116448_bb0120","first-page":"1","article-title":"Biochemical markers of myocardial damage","volume":"27","author":"Bodor","year":"2016","journal-title":"Ejifcc"},{"key":"10.1016\/j.taap.2023.116448_bb0125","article-title":"Kinetic method for the determination of serum LDH","volume":"24","author":"Buhl","year":"1978","journal-title":"Clin. Chem."},{"key":"10.1016\/j.taap.2023.116448_bb0130","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1038\/sj.onc.1210172","article-title":"A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1\/Mek-1\/Erk1\/2 pathway","volume":"26","author":"Carie","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2023.116448_bb0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/187152906779010746","article-title":"Carvedilol: just another beta-blocker or a powerful cardioprotector?","volume":"6","author":"Carreira","year":"2006","journal-title":"Cardiovas. & Haematol. Disord.-Drug Targets (Form. Curr. Drug Targ.-Cardiovas. & Hematol. Disorders)"},{"key":"10.1016\/j.taap.2023.116448_bb0140","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Cheang","year":"2009","journal-title":"JNCI: J. National Cancer Instit."},{"key":"10.1016\/j.taap.2023.116448_bb0145","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3892\/etm.2016.3140","article-title":"Effects of carvedilol reduce conjunctivitis through changes in inflammation, NGF and VEGF levels in a rat model","volume":"11","author":"Chen","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.taap.2023.116448_bb0150","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1124\/jpet.115.225375","article-title":"Early administration of carvedilol protected against doxorubicin-induced cardiomyopathy","volume":"355","author":"Chen","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2023.116448_bb0155","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","article-title":"Molecular pathways: beta-adrenergic signaling in cancer","volume":"18","author":"Cole","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2023.116448_bb0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.taap.2023.116448_bb0165","first-page":"25","article-title":"Doxorubicin cardiotoxicity: multiple targets and translational perspectives","volume":"2","author":"De Angelis","year":"2018","journal-title":"Cardiotoxicity"},{"key":"10.1016\/j.taap.2023.116448_bb0170","first-page":"189","article-title":"Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK\/Akt\/mTOR pathway and EGFR\/FAAD proteins","volume":"52","author":"De Ara\u00fajo Jr","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.taap.2023.116448_bb0175","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1388-9842(01)00129-5","article-title":"Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure","volume":"3","author":"de Boer","year":"2001","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.taap.2023.116448_bb0180","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1038\/sj.onc.1206044","article-title":"Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance","volume":"21","author":"Devarajan","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2023.116448_bb0185","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4103\/0973-1482.137664","article-title":"Carvedilol suppresses migration and invasion of malignant breast cells by inactivating Src involving cAMP\/PKA and PKC\u03b4 signaling pathway","volume":"10","author":"Dezong","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.taap.2023.116448_bb0190","doi-asserted-by":"crossref","first-page":"9566","DOI":"10.3748\/wjg.v21.i32.9566","article-title":"Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway","volume":"21","author":"Ding","year":"2015","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.taap.2023.116448_bb0195","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317692235","article-title":"Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway","volume":"39","author":"El-Ashmawy","year":"2017","journal-title":"Tumor Biol."},{"key":"10.1016\/j.taap.2023.116448_bb0200","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00394-017-1382-6","article-title":"Ginger extract adjuvant to doxorubicin in mammary carcinoma: study of some molecular mechanisms","volume":"57","author":"El-Ashmawy","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.taap.2023.116448_bb0205","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/0748233711434955","article-title":"The antitumor effects of tetrodotoxin and\/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice","volume":"29","author":"El-Dayem","year":"2013","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.taap.2023.116448_bb0210","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3892\/ijo_00000563","article-title":"Carvedilol in glioma treatment alone and with imatinib in vitro","volume":"36","author":"Erguven","year":"2010","journal-title":"Int. J. Oncol."},{"issue":"48","key":"10.1016\/j.taap.2023.116448_bb0215","first-page":"1","article-title":"The design of poly (lactide-co-glycolide) nanocarriers for medical applications","volume":"8","author":"Essa","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"102866","key":"10.1016\/j.taap.2023.116448_bb0220","first-page":"1","article-title":"Chitosan-encapsulated niosomes for enhanced oral delivery of atorvastatin","volume":"66","author":"Fayed","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.taap.2023.116448_bb0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/eurheartj\/17.suppl_B.24","article-title":"Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection","volume":"17","author":"Feuerstein","year":"1996","journal-title":"Eur. Heart J."},{"issue":"35","key":"10.1016\/j.taap.2023.116448_bb0230","first-page":"1","article-title":"The usefulness of lactate dehydrogenase measurements in current oncological practice","volume":"25","author":"Forkasiewicz","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.taap.2023.116448_bb0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lfs.2016.08.009","article-title":"Solid Ehrlich carcinoma reproduces functional and biological characteristics of cancer cachexia","volume":"162","author":"Frajacomo","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2023.116448_bb0240","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4238\/2015.January.30.10","article-title":"Effects of VEGF\/VEGFR\/K-ras signaling pathways on miRNA21 levels in hepatocellular carcinoma tissues in rats","volume":"14","author":"Gao","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.taap.2023.116448_bb0245","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mdp322","article-title":"Thresholds for therapies: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2009","volume":"20","author":"Goldhirsch","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2023.116448_bb0250","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast Cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2023.116448_bb0255","doi-asserted-by":"crossref","unstructured":"Haldar, R., Shaashua, L., Lavon, H., Lyons, Y.A., Zmora, O., Sharon, E., Birnbaum, Y., Allweis, T., Sood, A.K., Barshack, I.J.B., behavior, immunity, 2018. Perioperative inhibition of \u03b2-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome. Brain Behav. Immun. 73, 294\u2013309.","DOI":"10.1016\/j.bbi.2018.05.014"},{"key":"10.1016\/j.taap.2023.116448_bb0260","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"cell"},{"key":"10.1016\/j.taap.2023.116448_bb0265","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.biopha.2017.09.008","article-title":"The effects of \u03b2-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice","volume":"95","author":"Hanu\u0161ov\u00e1","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2023.116448_bb0270","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/10717544.2013.779332","article-title":"Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system","volume":"20","author":"Hasan","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/j.taap.2023.116448_bb0275","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/clinchem\/13.11.994","article-title":"Serum creatine phosphokinase: evaluation of a commercial spectrophotometric method","volume":"13","author":"Hess","year":"1967","journal-title":"Clin. Chem."},{"key":"10.1016\/j.taap.2023.116448_bb0280","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1158\/0008-5472.CAN-10-3471","article-title":"Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types","volume":"71","author":"Iliopoulos","year":"2011","journal-title":"Cancer Res."},{"issue":"1060","key":"10.1016\/j.taap.2023.116448_bb0285","first-page":"1","article-title":"Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy","volume":"14","author":"Jakob","year":"2008","journal-title":"World J. Gastroentol."},{"key":"10.1016\/j.taap.2023.116448_bb0290","series-title":"StatPearls","article-title":"Doxorubicin","author":"Johnson-Arbor","year":"2017"},{"key":"10.1016\/j.taap.2023.116448_bb0295","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0006-2952(99)00262-2","article-title":"Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity","volume":"58","author":"Jonsson","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2023.116448_bb0300","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.tice.2015.07.003","article-title":"Effect of metformin and adriamycin on transplantable tumor model","volume":"47","author":"Kabel","year":"2015","journal-title":"Tissue Cell"},{"key":"10.1016\/j.taap.2023.116448_bb0305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1349-7006.2003.tb01356.x","article-title":"Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil","volume":"94","author":"Kakumoto","year":"2003","journal-title":"Cancer Sci."},{"key":"10.1016\/j.taap.2023.116448_bb0310","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.xphs.2016.07.007","article-title":"Maximizing the therapeutic efficacy of imatinib mesylate\u2013loaded niosomes on human colon adenocarcinoma using box-Behnken design","volume":"106","author":"Kassem","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.taap.2023.116448_bb0315","first-page":"83","article-title":"Toxicity studies of trehalose and\/or methotrexate in mice","volume":"9","author":"Khamis","year":"2018","journal-title":"Res. J. Pharm., Biol. Chem. Sci."},{"key":"10.1016\/j.taap.2023.116448_bb0320","first-page":"3971","article-title":"Self-assembled biodegradable polymeric nanoparticles with improved solubility of carvedilol: preparation, characterisation and in vitro release kinetics","volume":"7","author":"Khan","year":"2016","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.taap.2023.116448_bb0325","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1007\/s13277-015-3655-0","article-title":"Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin","volume":"36","author":"Khedr","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.taap.2023.116448_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"384","key":"10.1016\/j.taap.2023.116448_bb0335","first-page":"1","article-title":"Anti-inflammatory and pro-angiogenic effects of beta blockers in a canine model of chronic ischemic cardiomyopathy: comparison between carvedilol and metoprolol","volume":"108","author":"Le","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.taap.2023.116448_bb0340","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2023.116448_bb0345","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/clc.4960080409","article-title":"Elevated CK-MB and CK-BB in serum and tumor homogenate of a patient with lung cancer","volume":"8","author":"Lee","year":"1985","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.taap.2023.116448_bb0350","article-title":"A novel drug delivery system: niosomes review","volume":"2","author":"Lohumi","year":"2012","journal-title":"J. Drug Deliv. Therapeut."},{"key":"10.1016\/j.taap.2023.116448_bb0355","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1369\/0022155411412599","article-title":"Estimation of immunohistochemical expression of VEGF in ductal carcinomas of the breast","volume":"59","author":"Maae","year":"2011","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.taap.2023.116448_bb0360","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10549-011-1348-y","article-title":"\u03b2-Adrenergic receptors (\u03b2-AR) regulate VEGF and IL-6 production by divergent pathways in high \u03b2-AR-expressing breast cancer cell lines","volume":"130","author":"Madden","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.taap.2023.116448_bb0365","first-page":"69","article-title":"High Creatine kinase (CK)-MB and lactate dehydrogenase in the absence of myocardial injury or infarction: a case report","volume":"6","author":"Maghamiour","year":"2014","journal-title":"J. Cardiovasc. Thorac. Res."},{"key":"10.1016\/j.taap.2023.116448_bb0370","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1038\/s41598-019-42357-w","article-title":"Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes","volume":"9","author":"Marinello","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2023.116448_bb0375","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00204-008-0304-z","article-title":"Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis","volume":"82","author":"Mat\u00e9s","year":"2008","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2023.116448_bb0380","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0024-3205(99)00362-8","article-title":"Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats","volume":"65","author":"Matsui","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2023.116448_bb0385","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1200\/JCO.2010.33.4441","article-title":"Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer","volume":"29","author":"Melhem-Bertrandt","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2023.116448_bb0390","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/sj.bjc.6604733","article-title":"Angiogenesis in pre-malignant conditions","volume":"99","author":"Menakuru","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2023.116448_bb0395","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12282-019-01014-w","article-title":"Preparation, characterization, and evaluation of the anticancer activity of artemether-loaded nano-niosomes against breast cancer","volume":"27","author":"Mirzaei-Parsa","year":"2020","journal-title":"Breast Cancer"},{"key":"10.1016\/j.taap.2023.116448_bb0400","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4172\/pharmaceutical-sciences.1000235","article-title":"Molecular mechanisms of cardiotoxicity: a review on major side-effect of doxorubicin","volume":"79","author":"Mobaraki","year":"2017","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.taap.2023.116448_bb0405","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2014.04.015","article-title":"Nano-niosomes as nanoscale drug delivery systems: an illustrated review","volume":"185","author":"Moghassemi","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.taap.2023.116448_bb0410","first-page":"88","article-title":"Suppression of myocardial injury markers following percutaneous coronary interventions by pre-treatment with carvedilol","volume":"6","author":"Moloudi","year":"2012","journal-title":"Int. Cardiovasc. Res. J."},{"key":"10.1016\/j.taap.2023.116448_bb0415","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.18632\/oncotarget.14119","article-title":"Use of non-selective \u03b2-blockers is associated with decreased tumor proliferative indices in early stage breast cancer","volume":"8","author":"Montoya","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2023.116448_bb0420","first-page":"155","article-title":"The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer","volume":"42","author":"Montoya","year":"2019","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2023.116448_bb0425","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.biopha.2018.06.051","article-title":"Umbilical cord blood-mesenchymal stem cells and carvedilol reduce doxorubicin-induced cardiotoxicity: possible role of insulin-like growth factor-1","volume":"105","author":"Mousa","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2023.116448_bb0430","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2169\/internalmedicine.43.1087","article-title":"Five cases of anthracycline-induced cardiomyopathy effectively treated with carvedilol","volume":"43","author":"Mukai","year":"2004","journal-title":"Intern. Med."},{"key":"10.1016\/j.taap.2023.116448_bb0435","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pbb.2019.04.003","article-title":"The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo","volume":"181","author":"Murnane","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.taap.2023.116448_bb0440","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0006-2952(99)00417-7","article-title":"Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation","volume":"59","author":"Noguchi","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2023.116448_bb0445","first-page":"1301","article-title":"Expression of the multidrug resistance-associated protein (MRP) gene in human cancers","volume":"1","author":"Nooter","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2023.116448_bb0450","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.taap.2023.116448_bb0455","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2023.116448_bb0460","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/030089169307900408","article-title":"Hyperthermic potentiation of cisplatin cytotoxicity on solid Ehrlich carcinoma","volume":"79","author":"Osman","year":"1993","journal-title":"Tumori J."},{"key":"10.1016\/j.taap.2023.116448_bb0465","first-page":"2375","article-title":"Ehrlich ascites carcinoma","volume":"10","author":"Ozaslan","year":"2011","journal-title":"Afr. J. Biotechnol."},{"key":"10.1016\/j.taap.2023.116448_bb0470","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/ijc.25589","article-title":"Retracted: norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1\u03b1 protein-dependent mechanism","volume":"128","author":"Park","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2023.116448_bb0475","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/bjc.2013.205","article-title":"\u03b2-Blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma","volume":"108","author":"Pasquier","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2023.116448_bb0480","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2174\/138161211796904812","article-title":"Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol","volume":"17","author":"Pereira","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.taap.2023.116448_bb0485","doi-asserted-by":"crossref","first-page":"628","DOI":"10.18632\/oncotarget.197","article-title":"Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival","volume":"1","author":"Powe","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2023.116448_bb0490","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.lfs.2018.03.023","article-title":"Toxicity of doxorubicin (Dox) to different experimental organ systems","volume":"200","author":"Pugazhendhi","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2023.116448_bb0495","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jat.1276","article-title":"Protection of multiple antioxidants Chinese herbal medicine on the oxidative stress induced by adriamycin chemotherapy","volume":"28","author":"Qin","year":"2008","journal-title":"J. Appl. Toxicol.: Int. J."},{"key":"10.1016\/j.taap.2023.116448_bb0500","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3329\/jafmc.v12i2.41109","article-title":"Role of carvedilol in prevention of adrenaline induced myocardial infraction in experimental animal","volume":"12","author":"Rahman","year":"2016","journal-title":"J. Armed Forces Med. College, Bangladesh"},{"key":"10.1016\/j.taap.2023.116448_bb0505","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-cancerbio-041916-065808","article-title":"The two faces of reactive oxygen species in cancer","volume":"1","author":"Reczek","year":"2017","journal-title":"Ann. Rev. Cancer Biol."},{"key":"10.1016\/j.taap.2023.116448_bb0510","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/01.CIR.99.6.786","article-title":"Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction","volume":"99","author":"Richards","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2023.116448_bb0515","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cbi.2015.12.020","article-title":"Carvedilol protects the kidneys of tumor-bearing mice without impairing the biodistribution or the genotoxicity of cisplatin","volume":"245","author":"Rodrigues","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2023.116448_bb0520","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/bjs.1800650314","article-title":"Cell viability studies on the exfoliated colonic cancer cell","volume":"65","author":"Rosenberg","year":"1978","journal-title":"J. British Surg."},{"key":"10.1016\/j.taap.2023.116448_bb0525","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22645","article-title":"Antitumor activity of sitagliptin and vitamin B12 on Ehrlich ascites carcinoma solid tumor in mice","volume":"35","author":"Salah","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.taap.2023.116448_bb0530","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00210-018-1579-0","article-title":"Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions","volume":"392","author":"Saleh","year":"2019","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"480","key":"10.1016\/j.taap.2023.116448_bb0535","first-page":"1","article-title":"Breast cancer subtypes present a differential production of reactive oxygen species (ROS) and susceptibility to antioxidant treatment","volume":"9","author":"Sarmiento-Salinas","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.taap.2023.116448_bb0540","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.taap.2023.116448_bb0545","first-page":"547","article-title":"Physicochemical and pharmacological evaluation of carvedilol-eudragit\u00ae RS100 electrosprayed nanostructures","volume":"22","author":"Selselehjonban","year":"2019","journal-title":"Iranian J. Basic Med. Sci."},{"key":"10.1016\/j.taap.2023.116448_bb0550","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10549-010-0822-2","article-title":"The \u03b22-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells","volume":"125","author":"Shi","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.taap.2023.116448_bb0555","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00059-011-3470-3","article-title":"Mechanisms and management of doxorubicin cardiotoxicity","volume":"36","author":"Shi","year":"2011","journal-title":"Herz"},{"key":"10.1016\/j.taap.2023.116448_bb0560","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","article-title":"The sympathetic nervous system induces a metastatic switch in primary breast cancer","volume":"70","author":"Sloan","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2023.116448_bb0565","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1006338232150","article-title":"\u03b2-Adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells","volume":"60","author":"Slotkin","year":"2000","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.taap.2023.116448_bb0570","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1200\/JCO.2012.43.9190","article-title":"Use of \u03b2-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study","volume":"31","author":"S\u00f8rensen","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2023.116448_bb0575","first-page":"387","article-title":"Inhibition of proliferation on some neoplastic cell lines-act of carvedilol and captopril","volume":"24","author":"Stanojkovic","year":"2005","journal-title":"J. Experiment. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.taap.2023.116448_bb0580","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/jphp.12516","article-title":"Colloidal carriers for extended absorption window of furosemide","volume":"68","author":"Sultan","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.taap.2023.116448_bb0585","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jddst.2017.08.003","article-title":"Peceosomes for Oral Delivery of Glibenclamide: In Vitro in Situ Correlation","volume":"41","author":"Sultan","year":"2017","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"10.1016\/j.taap.2023.116448_bb0590","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: more than a proliferation marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"},{"key":"10.1016\/j.taap.2023.116448_bb0595","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00001813-200404000-00001","article-title":"Carvedilol: a new candidate for reversal of MDR1\/P-glycoprotein-mediated multidrug resistance","volume":"15","author":"Takara","year":"2004","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.taap.2023.116448_bb0600","first-page":"1","article-title":"Oxidative stress: a novel strategy in cancer treatment","volume":"7","author":"Tandon","year":"2005","journal-title":"JK Sci."},{"key":"10.1016\/j.taap.2023.116448_bb0605","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","article-title":"Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma","volume":"12","author":"Thaker","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2023.116448_bb0610","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1369\/jhc.2009.954586","article-title":"Anti-human vascular endothelial growth factor (VEGF) antibody selection for immunohistochemical staining of proliferating blood vessels","volume":"58","author":"van der Loos","year":"2010","journal-title":"Journal of Histochemistry & Cytochemistry"},{"key":"10.1016\/j.taap.2023.116448_bb0615","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1590\/S0102-09352007000100025","article-title":"Influence of Agaricus blazei Murrill in solid Ehrlich tumor and popliteal lymph nodes in mice","volume":"59","author":"Ver\u00e7osa Junior","year":"2007","journal-title":"Arquivo Brasil. Med. Veterin. e Zoot."},{"key":"10.1016\/j.taap.2023.116448_bb0620","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jacc.2013.02.058","article-title":"The P-glycoprotein transport system and cardiovascular drugs","volume":"61","author":"Wessler","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.taap.2023.116448_bb0625","first-page":"31","author":"Whitlock","year":"2020"},{"issue":"20211033","key":"10.1016\/j.taap.2023.116448_bb0630","first-page":"1","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2022","journal-title":"Br. J. Radiol."},{"issue":"87","key":"10.1016\/j.taap.2023.116448_bb0635","first-page":"1","article-title":"Apoptosis in cancer: from pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.taap.2023.116448_bb0640","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/02652048.2012.717116","article-title":"Preparation, characterization and anticancer therapeutic efficacy of cisplatin-loaded niosomes","volume":"30","author":"Yang","year":"2013","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.taap.2023.116448_bb0645","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-3565(25)10363-7","article-title":"Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger","volume":"263","author":"Yue","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2023.116448_bb0650","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s11095-008-9793-y","article-title":"Naringenin enhances the anti-tumor effect of doxorubicin through selectively inhibiting the activity of multidrug resistance-associated proteins but not P-glycoprotein","volume":"26","author":"Zhang","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2023.116448_bb0655","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biopha.2018.07.037","article-title":"Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy","volume":"109","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"35267","key":"10.1016\/j.taap.2023.116448_bb0660","first-page":"1","article-title":"Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23000868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23000868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:02:15Z","timestamp":1758574935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X23000868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":132,"alternative-id":["S0041008X23000868"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2023.116448","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential cardioprotective and anticancer effects of carvedilol either free or as loaded nanoparticles with or without doxorubicin in solid Ehrlich carcinoma-bearing mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2023.116448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116448"}}